Market Research Logo

Morocco Pharmaceuticals & Healthcare Q2 2019

Morocco Pharmaceuticals & Healthcare Q2 2019

Key View:

The Moroccan pharmaceutical market is expected to experience relatively modest growth in the coming years. Thegovernment's commitment to improving healthcare via the expansion of health insurance coverage and the country's growing non-communicable disease burden will provide significant tailwinds for future medicine sales. We believe generic drug makers will be themain beneficiaries as the state adopts a pro-generic stance and continues to slash drug prices. In addition, the country's lowpurchasing power, small pensionable population and inadequate public health system will dampen the demand for high-valuechronic disease treatments limiting innovative pharmaceutical sales.


Key View
SWOT
Industry Forecast
Pharmaceutical Market
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
MENA Innovative Pharmaceuticals Risk/Reward Index
Morocco Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Laprophan
Pfizer
Sanofi
Sothema
Morocco Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report